WHAT:
Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) West Coast conference January 28-29 in Burlingame. Attendees are invited to stop by Rho’s booth (#4) to speak to their R&D expert David Shoemaker who has extensive experience in many therapeutic areas ranging from Oncology, Hematology, Circulatory, Respiratory, Nervous System, Transplants and more. David can offer insight on orphan drug development, accelerated approval programs and analgesia development.
WHO:
Rho experts available for interview at OCT:
- David Shoemaker, Ph.D. Senior Vice President, Research and Development
- David Cass, Senior Director, Business Development
WHEN:
January 28-29, 2014
WHERE:
Hyatt Regency San Francisco Airport
1333 Bayshore Highway
Burlingame, California 94010
DETAILS:
For media inquiries please contact Jessica Highsmith at Largemouth Communications, (919) 459-6456, [email protected] .
ABOUT:
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 25 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.